Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Frontiers in Microbiology
|
October 19, 2018
Evaluation of Galactomannan Testing, the <i>Aspergillus</i>-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis
Helmut J F Salzer, Juergen Prattes, Holger Flick, et al.
The Journal of Infection
|
November 20, 2025
Lipoarabinomannan (LAM) for the diagnosis of tuberculosis from sputum
Steffen Pichlo, Patricia Sanchez Carballo, Maja Reimann, et al.
Frontiers in Immunology
|
June 29, 2026
PD-L1-centric whole blood-based immune signature profiles of tuberculosis patients during therapy
Johanna Eggeling, Martina Sester, Christoph Lange, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 25, 2023
Update on the diagnosis of tuberculosis
Irina Kontsevaya, Andrea Maurizio Cabibbe, Daniela Maria Cirillo, et al.
Pathogens & Immunity
|
June 28, 2024
A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis
Nika Zielinski, Dragos Baiceanu, Antonela Dragomir, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2021
Design of Multidrug-Resistant Tuberculosis Treatment Regimens Based on DNA Sequencing
Hans-Peter Grobbel, Matthias Merker, Niklas Köhler, et al.
Tuberculosis (Edinburgh, Scotland)
|
February 13, 2026
Towards model-informed precision dosing of clofazimine, moxifloxacin, and terizidone/cycloserine in the treatment of drug-resistant tuberculosis: An external model evaluation study
Emily Behrens, Niklas Köhler, Max Münchow, et al.
ACS Infectious Diseases
|
June 28, 2022
Tuberculostearic Acid-Containing Phosphatidylinositols as Markers of Bacterial Burden in Tuberculosis
Julius Brandenburg, Jan Heyckendorf, Franziska Marwitz, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
May 27, 2021
Perspectives for systems biology in the management of tuberculosis
Irina Kontsevaya, Christoph Lange, Patricia Comella-Del-Barrio, et al.
Nature Medicine
|
February 16, 2024
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial
Andreas H Diacon, Clifton E Barry, Alex Carlton, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Frontiers in Microbiology
|
October 19, 2018
Evaluation of Galactomannan Testing, the <i>Aspergillus</i>-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis
Helmut J F Salzer, Juergen Prattes, Holger Flick, et al.
The Journal of Infection
|
November 20, 2025
Lipoarabinomannan (LAM) for the diagnosis of tuberculosis from sputum
Steffen Pichlo, Patricia Sanchez Carballo, Maja Reimann, et al.
Frontiers in Immunology
|
June 29, 2026
PD-L1-centric whole blood-based immune signature profiles of tuberculosis patients during therapy
Johanna Eggeling, Martina Sester, Christoph Lange, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 25, 2023
Update on the diagnosis of tuberculosis
Irina Kontsevaya, Andrea Maurizio Cabibbe, Daniela Maria Cirillo, et al.
Pathogens & Immunity
|
June 28, 2024
A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis
Nika Zielinski, Dragos Baiceanu, Antonela Dragomir, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2021
Design of Multidrug-Resistant Tuberculosis Treatment Regimens Based on DNA Sequencing
Hans-Peter Grobbel, Matthias Merker, Niklas Köhler, et al.
Tuberculosis (Edinburgh, Scotland)
|
February 13, 2026
Towards model-informed precision dosing of clofazimine, moxifloxacin, and terizidone/cycloserine in the treatment of drug-resistant tuberculosis: An external model evaluation study
Emily Behrens, Niklas Köhler, Max Münchow, et al.
ACS Infectious Diseases
|
June 28, 2022
Tuberculostearic Acid-Containing Phosphatidylinositols as Markers of Bacterial Burden in Tuberculosis
Julius Brandenburg, Jan Heyckendorf, Franziska Marwitz, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
May 27, 2021
Perspectives for systems biology in the management of tuberculosis
Irina Kontsevaya, Christoph Lange, Patricia Comella-Del-Barrio, et al.
Nature Medicine
|
February 16, 2024
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial
Andreas H Diacon, Clifton E Barry, Alex Carlton, et al.
Page
of 4